{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "61958-2501",
      "generic_name": "bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate",
      "labeler_name": "Gilead Sciences, Inc.",
      "brand_name": "Biktarvy",
      "active_ingredients": [
        {
          "name": "BICTEGRAVIR SODIUM",
          "strength": "50 mg/1"
        },
        {
          "name": "EMTRICITABINE",
          "strength": "200 mg/1"
        },
        {
          "name": "TENOFOVIR ALAFENAMIDE FUMARATE",
          "strength": "25 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "61958-2501-1",
          "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2501-1)",
          "marketing_start_date": "20180207",
          "sample": false
        },
        {
          "package_ndc": "61958-2501-2",
          "description": "7 TABLET in 1 BOTTLE, PLASTIC (61958-2501-2)",
          "marketing_start_date": "20180726",
          "sample": false
        },
        {
          "package_ndc": "61958-2501-3",
          "description": "30 TABLET in 1 BLISTER PACK (61958-2501-3)",
          "marketing_start_date": "20210824",
          "sample": false
        },
        {
          "package_ndc": "61958-2501-5",
          "description": "30 TABLET in 1 BLISTER PACK (61958-2501-5)",
          "marketing_start_date": "20260330",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "NDA",
      "dosage_form": "TABLET",
      "spl_id": "261dcc2a-c849-46b1-abf6-4981ed2c60bc",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20180207",
      "product_id": "61958-2501_261dcc2a-c849-46b1-abf6-4981ed2c60bc",
      "application_number": "NDA210251",
      "brand_name_base": "Biktarvy",
      "pharm_class": [
        "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
        "Nucleosides [CS]",
        "Nucleosides [CS]"
      ]
    }
  ]
}